Resveratrol sits at the center of a familiar longevity story: a plant compound found in grapes, berries, peanuts, and Japanese knotweed that seems to influence aging pathways in laboratory studies. In cells and animals, it touches systems tied to inflammation, oxidative stress, mitochondria, blood vessel function, insulin signaling, and stress resistance. Those signals make resveratrol interesting, but human aging is not a petri dish. The evidence in people is more modest, mixed, and dose-sensitive than the marketing suggests.
Resveratrol is best understood as a biologically active polyphenol with plausible mechanisms and limited clinical proof, not as a proven lifespan supplement. Human trials show possible benefits in selected metabolic, vascular, inflammatory, and cognitive contexts, but they do not show that resveratrol extends human life. Its low bioavailability, variable formulations, and gastrointestinal side effects at higher doses matter when deciding whether it belongs in a longevity plan.
Table of Contents
- What Resveratrol Is
- How Resveratrol Interacts with Longevity Pathways
- What Human Studies Actually Show
- Dose, Forms, and Bioavailability
- Safety, Side Effects, and Interactions
- Who Might Consider Resveratrol
- How to Use Resveratrol Practically
- Final Perspective
What Resveratrol Is
Resveratrol is a stilbene polyphenol, a plant defense compound produced when plants face stress such as fungal attack, ultraviolet light, or injury. The form most discussed in supplements is trans-resveratrol, the more biologically active and commonly measured form. Food sources include red grape skins, red wine, blueberries, cranberries, mulberries, pistachios, peanuts, and cocoa, but the amounts in food are small compared with supplements.
A glass of red wine usually provides only about 0.1–2 mg of resveratrol. Many supplements provide 100–500 mg per capsule. That difference matters. The popular “French paradox” story linked red wine intake with lower cardiovascular risk despite saturated fat intake, but wine contains many compounds, and alcohol itself carries health risks. Resveratrol should not be used as a reason to drink wine.
Supplement resveratrol is often extracted from Japanese knotweed, listed botanically as Polygonum cuspidatum or Reynoutria japonica. Some products use grape-derived resveratrol, but grape sourcing does not automatically make a product stronger, safer, or more effective. The amount of trans-resveratrol, third-party testing, contaminants, and excipients matter more than the romantic appeal of the source.
Resveratrol belongs in the broader family of polyphenols, which also includes flavanols from cocoa, catechins from tea, anthocyanins from berries, and olive oil phenolics. Food-first polyphenol intake usually brings fiber, minerals, and other protective compounds with it. A supplement isolates one molecule and raises exposure far beyond normal diet levels. That is sometimes useful in research, but it also changes the safety and interpretation.
In longevity discussions, resveratrol attracts attention because it overlaps with pathways also discussed in mTOR and AMPK signaling, mitochondrial function, and cellular stress response. The overlap is real, but pathway activation does not equal proven healthspan extension. A compound must improve outcomes in people, not just move markers in cells.
How Resveratrol Interacts with Longevity Pathways
Resveratrol has several proposed mechanisms. None should be viewed as a single “anti-aging switch.” Its actions vary by dose, tissue, metabolic health, formulation, and study model.
SIRT1 and cellular stress response
SIRT1 is an enzyme involved in DNA repair, metabolism, inflammation control, circadian biology, and stress adaptation. Early resveratrol research gained attention because resveratrol appeared to activate SIRT1, a pathway linked with calorie restriction biology. Later work showed that the relationship is more complicated than direct activation in every setting.
In practical terms, resveratrol seems to influence stress-response networks rather than simply turning on a longevity gene. SIRT1 activity also depends on NAD availability, energy status, sleep, fasting patterns, exercise, and inflammation. That is why resveratrol does not replace the basics that maintain cellular energy metabolism. Readers comparing NAD-related supplements should treat resveratrol as a separate compound, not as a substitute for a broader NAD plus aging discussion.
AMPK, insulin signaling, and metabolic stress
AMPK acts like a cellular fuel gauge. When energy is low, AMPK helps shift cells toward fat oxidation, glucose uptake, mitochondrial maintenance, and repair. Resveratrol has been shown in experimental systems to influence AMPK-related signaling. This partly explains why trials often focus on glucose, insulin, liver fat, blood pressure, and lipid markers.
The metabolic evidence is not uniform. People with insulin resistance, type 2 diabetes, metabolic syndrome, or fatty liver often show more room for improvement than already healthy adults. Even then, results differ across studies. Dose, baseline health, trial duration, background medication use, and product quality all affect outcomes.
Resveratrol is sometimes compared with berberine for glucose and AMPK, but the clinical profiles differ. Berberine has stronger evidence for glucose and lipid lowering, while resveratrol has broader but less consistent signals across inflammation, vascular function, and cellular stress pathways.
Inflammation and oxidative stress
Resveratrol influences inflammatory signaling, including pathways linked with NF-κB, cytokines, endothelial irritation, and oxidative stress. In plain language, it appears to calm some cellular alarm signals in certain contexts. That does not mean it is a simple antioxidant.
Many longevity mechanisms rely on signals that look stressful in the short term. Exercise creates oxidative and inflammatory signals that help the body adapt. Blocking every stress signal is not desirable. Resveratrol seems more like a modulator than a blunt suppressor, but high-dose antioxidant-style supplementation around training remains an area of caution.
This is especially relevant for people who take several anti-inflammatory supplements at once: curcumin, quercetin, omega-3s, green tea extract, sulforaphane, and resveratrol. Combining many compounds makes it harder to know what helps, what causes side effects, and what interferes with adaptation.
Mitochondria and muscle
Mitochondria produce usable cellular energy and help regulate metabolism, inflammation, and cell survival. Resveratrol has improved mitochondrial markers in some laboratory and human studies, but functional outcomes in people remain inconsistent. A change in mitochondrial enzyme activity or gene expression does not always produce better strength, walking speed, VO₂max, or daily energy.
The exercise question is especially nuanced. In some studies, resveratrol combined with exercise supported certain markers or functions. In others, high-dose antioxidant-like supplementation seemed to blunt some training adaptations. The safest interpretation is that resveratrol is not a replacement for aerobic training, resistance training, protein adequacy, or recovery. It is a candidate add-on, not the engine of mitochondrial health.
Blood vessel function
Blood vessels age through stiffness, endothelial dysfunction, inflammation, oxidative stress, blood pressure load, and plaque development. Resveratrol’s vascular interest comes from nitric oxide signaling, endothelial function, and inflammatory effects. Some human trials show modest improvements in blood pressure or vascular markers, especially in people with cardiometabolic risk.
Still, resveratrol does not replace proven cardiovascular risk management. ApoB, non-HDL cholesterol, blood pressure, smoking status, glucose control, kidney function, sleep apnea, and body composition carry much stronger evidence. Anyone using supplements for vascular aging should also understand ApoB and non-HDL cholesterol rather than relying on polyphenols to offset untreated risk.
What Human Studies Actually Show
Human resveratrol research includes small randomized trials, metabolic studies, disease-specific trials, umbrella reviews, and systematic reviews. The overall pattern is clear: resveratrol has biological activity in people, but benefits are inconsistent and usually modest. The evidence is strongest for selected intermediate markers, not for longer life, fewer heart attacks, dementia prevention, or broad rejuvenation.
| Outcome area | What studies suggest | How to interpret it |
|---|---|---|
| Glucose and insulin | Some trials report lower fasting glucose, insulin resistance markers, or blood pressure in people with type 2 diabetes or metabolic syndrome. | Most relevant when baseline metabolic risk is present; not a substitute for nutrition, activity, sleep, or prescribed therapy. |
| Lipids | Effects on triglycerides, HDL, LDL, and total cholesterol are mixed. | Do not use resveratrol as a primary lipid-lowering strategy. |
| Inflammation | Some meta-analyses show reductions in inflammatory markers in cardiovascular or metabolic populations. | Effects are marker-based and not proof of fewer clinical events. |
| Body weight and fat | Reviews show inconsistent or small effects on weight, BMI, waist circumference, and body fat. | Resveratrol is not a meaningful weight-loss supplement. |
| Cognition | Some small trials suggest possible benefits in memory or cerebral blood flow, especially in postmenopausal adults. | Promising but not strong enough to treat or prevent cognitive decline. |
| Exercise and muscle | Findings vary; some studies suggest support, while others raise concern about blunted training adaptation. | Use caution with high doses around training blocks. |
| Lifespan | No human trial shows that resveratrol extends lifespan. | Claims about longer life remain unproven. |
Metabolic health
The most practical human evidence involves metabolic risk. Trials and reviews in people with type 2 diabetes, metabolic syndrome, or fatty liver have reported improvements in some measures such as fasting glucose, insulin resistance, systolic blood pressure, and liver-related markers. These findings are not universal. Some well-designed studies found no meaningful benefit.
A useful way to read the data is to separate “signal” from “solution.” Resveratrol has a metabolic signal. It is not a complete metabolic solution. A person with rising A1c, fasting insulin, high waist circumference, high triglycerides, poor sleep, and low activity will usually gain more from fixing the foundations than from adding resveratrol. Tracking A1c, fasting glucose, and fasting insulin gives a clearer picture than judging success by how a supplement feels.
Cardiovascular and inflammatory markers
Resveratrol’s cardiovascular evidence centers on endothelial function, blood pressure, inflammatory markers, and oxidative stress. Some analyses in people with cardiovascular disease or related risk factors suggest anti-inflammatory effects. Other trials show small or no effects.
The phrase “supports heart health” is too vague for this evidence. A more accurate statement is: resveratrol might improve selected vascular or inflammatory markers in some higher-risk adults, but it has not been shown to prevent cardiovascular events. That distinction matters because heart attack, stroke, and heart failure are outcome endpoints. C-reactive protein, nitric oxide signaling, and blood pressure are intermediate markers.
If inflammation is the reason someone is considering resveratrol, it is worth measuring the context. Persistent hs-CRP elevation, gum disease, poor sleep, visceral fat, smoking, untreated sleep apnea, autoimmune activity, and chronic infection all tell different stories. A broader inflammation marker workup is often more useful than guessing.
Cognition and brain aging
Resveratrol reaches brain-related conversations because it affects blood vessels, inflammation, oxidative stress, mitochondrial signaling, and possibly cerebral blood flow. Some studies in older adults and postmenopausal women report improvements in memory-related measures or vascular brain markers. These trials are generally small and often use specific populations, doses, and durations.
Resveratrol should not be described as a dementia-prevention supplement. Cognitive aging is shaped by blood pressure, hearing loss, sleep apnea, diabetes, physical activity, education, social connection, depression, medications, and vascular disease. Resveratrol might fit as a research-informed add-on in selected adults, but it sits far below proven brain-health levers.
Body composition and weight
Resveratrol is not a reliable fat-loss tool. Reviews of weight, BMI, waist circumference, and body fat show mixed findings. Any changes tend to be small compared with calorie intake, protein distribution, resistance training, daily steps, sleep quality, and medication effects.
This matters because weight-loss marketing often borrows longevity language. A supplement that nudges AMPK in cells does not automatically produce meaningful fat loss in real life. Someone using resveratrol for body composition should define success with actual measurements, not promises from pathway diagrams.
Exercise adaptation
The exercise literature is one of the most important caution areas. Resveratrol has been tested alongside training because it influences mitochondria and oxidative stress. Results do not point in one simple direction. Some studies in older adults suggest benefits when paired with exercise. Others raise concern that resveratrol, especially at higher doses, might reduce some exercise-induced improvements.
The safest approach is to avoid high-dose resveratrol during a focused training adaptation phase unless a clinician or sports nutrition professional has a clear reason. Training works partly because the body senses stress and adapts. Supplements that dampen signaling too much risk reducing the return on exercise.
Dose, Forms, and Bioavailability
Resveratrol dosing in human trials ranges widely, from about 20 mg per day to several grams per day. Common supplement doses fall between 100 and 500 mg per day. Higher doses are not automatically better. The dose that changes a biomarker in a short trial is not the same as the dose a person should take for years.
Bioavailability is the major challenge. After oral intake, resveratrol is absorbed but rapidly metabolized into glucuronide and sulfate forms. Blood levels of free resveratrol stay low. This does not mean resveratrol is useless; metabolites might still have activity, and tissues might see effects not captured by simple blood levels. It does mean product claims based only on milligrams are incomplete.
Common forms
Most products use trans-resveratrol capsules or tablets. Some combine resveratrol with quercetin, piperine, phospholipids, micronized particles, or emulsified delivery systems. These strategies aim to raise absorption or slow metabolism. Better absorption is not always better safety. A product that raises exposure more strongly might also raise the chance of side effects or interactions.
Japanese knotweed extracts sometimes provide high trans-resveratrol content, but they also require quality control for contaminants. Grape extracts often contain lower resveratrol levels and other polyphenols. Combination products blur interpretation because benefits or side effects might come from other ingredients.
Pterostilbene, a related compound found in blueberries and grapes, is often marketed as a more bioavailable “cousin” of resveratrol. It has different pharmacokinetics and a different evidence base, so it should be judged separately. A comparison of pterostilbene and resveratrol is useful before assuming they are interchangeable.
Food versus supplements
Food sources provide small resveratrol doses within a complex matrix of fiber, minerals, and other polyphenols. Berries, peanuts, cocoa, and grape skins fit well in a longevity-style diet. Red wine is a poor resveratrol strategy because the dose is low and alcohol adds risk, especially for sleep, blood pressure, liver health, cancer risk, and atrial fibrillation.
Supplements create pharmacologic exposure. That is useful for trials, but it changes the decision. A 250 mg capsule is not the same as eating grapes. It is a concentrated intervention that deserves the same careful thinking as any other nutraceutical.
Practical dose ranges
A conservative supplement range is 100–250 mg per day of trans-resveratrol with food. Many studies use 250–500 mg per day. Doses of 1,000 mg per day and above show more gastrointestinal side effects and are harder to justify for general longevity use without medical supervision.
| Dose range | Typical context | Practical interpretation |
|---|---|---|
| Dietary intake | Usually below a few mg per day from foods | Best viewed as part of a polyphenol-rich eating pattern. |
| 100–250 mg/day | Common conservative supplement range | Reasonable starting range for adults who choose to trial it. |
| 250–500 mg/day | Common clinical trial and commercial range | Higher exposure; monitor tolerance and biomarkers. |
| 1,000 mg/day or more | Research or aggressive supplement use | Higher side-effect risk; avoid without clinician oversight. |
| Several grams/day | Specialized research settings | Not appropriate for routine longevity supplementation. |
Taking resveratrol with a meal that contains some fat may improve absorption and reduce stomach irritation. Evening use bothers some people if it causes reflux, nausea, or sleep disruption. Morning or midday dosing with food is the simplest starting point.
Safety, Side Effects, and Interactions
Resveratrol is usually well tolerated at low-to-moderate doses in short human studies. The most common side effects are gastrointestinal: nausea, loose stools, diarrhea, abdominal discomfort, gas, and reflux. Headache and fatigue are also reported. Side effects become more likely as doses approach or exceed 1,000 mg per day.
Safety evidence is less reassuring for long-term daily use over many years because most trials are short. A compound that appears safe for 8–16 weeks still needs caution when used indefinitely. This is especially true for older adults taking medications.
Medication interactions
Resveratrol has antiplatelet and anticoagulant-relevant signals. People using warfarin, direct oral anticoagulants, aspirin, clopidogrel, or other blood-thinning regimens should not add resveratrol casually. The concern is not guaranteed harm; it is unpredictable bleeding risk, especially when combined with fish oil, garlic extract, ginkgo, curcumin, or high-dose vitamin E.
Resveratrol also interacts with drug-metabolizing enzymes and transporters in experimental settings. That raises caution for people taking multiple prescriptions, especially narrow-therapeutic-index drugs. Cancer therapies, immunosuppressants, seizure medications, anticoagulants, and hormone-sensitive treatments deserve extra care.
People scheduled for surgery, dental procedures, colonoscopy with polyp removal, or injections should tell their clinician about resveratrol and other supplements. Many clinicians advise stopping nonessential supplements 1–2 weeks before procedures, especially those with bleeding or anesthesia concerns.
Hormone-sensitive conditions
Resveratrol has estrogen-related activity in laboratory systems. It does not act exactly like estrogen, but it interacts with estrogen receptors in ways that vary by tissue and context. People with hormone-sensitive cancers, a history of breast cancer, endometriosis, uterine fibroids, or those using hormone therapy should discuss resveratrol before using it.
This caution is not a claim that resveratrol causes hormone-sensitive disease. It means the biology is complex enough that self-directed high-dose use is not wise in these contexts.
Liver and kidney considerations
Clinically apparent liver injury from resveratrol appears rare, but high doses have been associated with mild liver enzyme changes in some studies. People with active liver disease, unexplained ALT or AST elevation, heavy alcohol intake, or fatty liver should avoid high doses and track labs if they use it.
Kidney safety data are limited for people with chronic kidney disease. Anyone with reduced eGFR, albuminuria, transplant history, or complex medication use should get clinician input first. For healthy adults, routine low-dose use appears low risk, but “low risk” does not mean “risk-free.”
Pregnancy, fertility treatment, and children
Pregnant people, breastfeeding people, children, and those undergoing fertility treatment should avoid resveratrol supplementation unless a qualified clinician specifically recommends it. Food-level intake from berries, grapes, and peanuts is a different matter. Concentrated capsules create exposures that have not been established as safe in these groups.
Quality concerns
Dietary supplements vary in purity and accuracy. Choose products that list trans-resveratrol clearly, provide the amount per serving, and use independent testing when possible. Avoid proprietary blends that hide doses. Be cautious with products that combine resveratrol with many stimulants, hormone-active compounds, or absorption enhancers.
Quality also matters because Japanese knotweed extracts may vary in additional constituents. A clean label does not prove clean manufacturing. Third-party testing from recognized programs gives more confidence than marketing language.
Who Might Consider Resveratrol
Resveratrol is most reasonable for adults who understand its limits and want to run a careful, measurable trial. It is least reasonable for people seeking a shortcut around untreated metabolic, cardiovascular, sleep, or lifestyle issues.
Adults with insulin resistance, metabolic syndrome, elevated inflammatory markers, or vascular risk may find resveratrol worth discussing with a clinician, especially when core treatment is already in place. It might also interest postmenopausal adults focused on vascular and cognitive aging, though the evidence remains preliminary.
Resveratrol is less compelling for young, healthy, active adults with normal blood pressure, normal glucose markers, low inflammation, excellent sleep, and no cardiometabolic risk. In that setting, benefits are harder to detect and the risk of interfering with training adaptation becomes more relevant.
A reasonable candidate profile looks like this:
- Age 40 or older, with a clear healthspan target rather than vague anti-aging hopes.
- Stable medications and no major bleeding risk.
- Baseline labs available for glucose, lipids, liver enzymes, kidney function, and inflammation when relevant.
- Willingness to stop if side effects, lab changes, or no measurable benefit appear.
- Nutrition, exercise, sleep, and medical care already addressed.
People who should avoid self-directed use include those on anticoagulants or antiplatelet therapy, those with upcoming surgery, pregnant or breastfeeding people, children, people with hormone-sensitive cancer history unless cleared by their oncology team, and adults with complex liver, kidney, or medication issues.
Resveratrol also does not make sense as part of a large “longevity stack” started all at once. Combining it with fisetin, quercetin, curcumin, berberine, green tea extract, spermidine, NAD precursors, and high-dose antioxidants makes cause and effect impossible to identify. It also raises the chance of digestive side effects and interactions.
How to Use Resveratrol Practically
A practical resveratrol trial should answer a simple question: did this supplement improve a specific marker, symptom, or function enough to justify continued use? Without that structure, resveratrol becomes another indefinite capsule with unclear value.
Start with a clear reason
Good reasons are specific. Examples include elevated fasting insulin, borderline blood pressure, high hs-CRP after obvious causes have been addressed, or interest in vascular support during midlife. Weak reasons include “anti-aging,” “cellular repair,” “French paradox,” or “I heard it activates sirtuins.”
Choose one main outcome before starting. For metabolic goals, use glucose, A1c, fasting insulin, waist circumference, triglycerides, or blood pressure. For vascular goals, home blood pressure and lipid markers matter more than subjective energy. For inflammation goals, hs-CRP can help, but only when interpreted with context.
Use one change at a time
Start resveratrol without adding several other supplements in the same month. This prevents confusion. If digestion worsens, sleep changes, or blood pressure drops, you need to know what caused it. This is the same logic used in N of 1 longevity experiments: define the intervention, track a few markers, and decide based on results.
A simple plan:
- Record baseline labs, blood pressure, waist measurement, symptoms, medications, and current supplements.
- Choose a conservative dose, usually 100–250 mg/day of trans-resveratrol with food.
- Keep diet, exercise, sleep schedule, and other supplements steady for 8–12 weeks.
- Repeat the markers tied to the reason for use.
- Continue only if the benefit is clear, side effects are absent, and the safety context remains acceptable.
Monitor the right markers
For most adults, a basic safety and effect panel includes fasting glucose or A1c, fasting insulin when metabolic health is the target, lipid panel with ApoB or non-HDL cholesterol, ALT and AST, creatinine with eGFR, and hs-CRP if inflammation is the reason for use. Blood pressure should be measured at home rather than guessed from occasional office readings.
People using resveratrol for fatty liver or metabolic syndrome should avoid assuming liver benefits. ALT, AST, GGT, platelet count, FIB-4, ultrasound findings, and waist change offer better feedback. A structured NAFLD screening approach is more reliable than relying on a supplement narrative.
Know when to stop
Stop resveratrol if it causes persistent diarrhea, nausea, reflux, headaches, unusual bruising, nosebleeds, rash, fatigue, or sleep disruption. Stop before surgery or procedures if instructed by your clinician. Stop if liver enzymes rise without another clear reason. Stop if 8–12 weeks produce no meaningful change in the marker you chose.
Stopping is not failure. It is good supplement hygiene. Longevity practice improves when ineffective interventions are removed, not when every promising compound stays in the stack forever.
Do not pair it with alcohol for “resveratrol benefits”
Red wine is a poor delivery system for resveratrol. The amount of resveratrol is low, and alcohol worsens several longevity-relevant risks. Alcohol disrupts sleep architecture, raises blood pressure in dose-dependent patterns, increases cancer risk, adds calories, worsens reflux, and triggers atrial fibrillation in susceptible people. Eating berries or using a measured supplement is a cleaner way to study resveratrol exposure.
Final Perspective
Resveratrol remains scientifically interesting because it touches several aging-related pathways at once: SIRT1-linked stress response, AMPK signaling, inflammation, endothelial function, oxidative stress, and mitochondrial biology. That breadth explains why it continues to appear in longevity discussions. It also explains why the evidence is difficult to interpret. A compound that does many things in cells will not necessarily produce one clear outcome in humans.
The strongest case for resveratrol is not “live longer.” It is a cautious, measurable trial in selected adults with metabolic, vascular, or inflammatory risk, using a moderate dose and a clear stop rule. The weakest case is high-dose daily use by healthy adults based on pathway claims.
Resveratrol also teaches a larger lesson about longevity supplements. Mechanisms matter, but outcomes matter more. Biomarkers help, but they do not replace clinical endpoints. Natural origin does not guarantee safety. More absorption does not always mean better results. A supplement that looks promising in a review still needs to earn its place in a real person’s plan.
For most adults, the better first move is a polyphenol-rich diet: berries, cocoa, tea, coffee, colorful plants, legumes, nuts, extra-virgin olive oil, and herbs. That pattern supplies many compounds in food-level doses and supports gut, vascular, and metabolic health at the same time. A broader polyphenol-rich food strategy gives a wider base than relying on resveratrol alone.
When used, resveratrol should stay in proportion. It is a candidate nutraceutical with plausible mechanisms, mixed human evidence, and generally manageable safety at moderate doses. It is not a proven longevity drug, not a wine excuse, not a replacement for cardiometabolic care, and not a supplement to stack blindly. The best use is careful, modest, and measurable.
References
- Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities 2024 (Systematic Review)
- Effects and safety of resveratrol supplementation in older adults: A comprehensive systematic review 2024 (Systematic Review)
- Anti-inflammatory effects of resveratrol in patients with cardiovascular disease: A systematic review and meta-analysis of randomized controlled trials 2022 (Systematic Review)
- Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review 2022 (Systematic Review)
- The effect of resveratrol supplementation on obesity indices: a critical umbrella review of interventional meta-analyses 2025 (Umbrella Review)
- Resveratrol 2024 (Review)
Disclaimer
This article is educational and does not replace care from a qualified clinician, pharmacist, or registered dietitian. Resveratrol supplements may interact with medications, affect bleeding risk, and cause side effects, especially at higher doses or in people with medical conditions. Discuss resveratrol with a qualified professional before using it if you take prescription medications, have liver or kidney disease, have a hormone-sensitive condition, are pregnant or breastfeeding, or have surgery planned.
